|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of goods sold | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Selling, general and administrative | |||||
| Total operating expenses | |||||
| Loss from continuing operations | |||||
| Other income (expense): | |||||
| Warrant issuance costs | |||||
| Research and development expense | |||||
| Depreciation and amortization expense | |||||
| Intangible asset impairment | |||||
| API asset impairment | |||||
| Change in fair value of derivative liability | |||||
| Change in fair value of warrant liability | |||||
| Loss on issuance of Series A Preferred Stock | |||||
| Interest income | |||||
| Interest expense, promissory note | |||||
| Total other income, net | |||||
| Loss before income taxes | |||||
| Provision for income taxes | |||||
| Loss from continuing operations, net of tax | |||||
| Gain from assignment of subsidiaries and Vivus settlement | |||||
| Less loss from discontinued operations | |||||
| Net income (loss) | |||||
| Preferred stock dividend and cash premiums | |||||
| Preferred stock accretion | |||||
| Net loss attributable to Common Stockholders | |||||
| Deemed dividend on Warrants | |||||
| Series A Preferred warrants | |||||
| Series A Warrants | |||||
| Net loss per common share | |||||
| Net loss from continuing operations attributable to common stockholders | |||||
| Gain (loss) from discontinued operations attributable to common stockholders | |||||
| Basic - continuing operations (in dollars per share) | |||||
| Diluted - continuing operations (in dollars per share) | |||||
| Basic - discontinued operations, assignment and settlement | |||||
| Diluted - discontinued operations, assignment and settlement | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Weighted average common shares outstanding | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
Loading...